Skip to main content
< Back
About
About the conference
App
Organisers & Partners
Latest updates
Press room
Registration
Venue 22
About the venue
Rooms
Call for abstracts
Programme 22
Tracks 22
Speakers 22
Side events 22
Subscribe
days
hours
minutes
seconds
Next track
Addictions and mental health
In programme
14 sessions
68 presentations
View the programme
About
This track is co-produced by the
Society for the Study of Addiction (SSA)
.
Addiction, mental health and co-occurring mental illness in different populations.
Addiction and trauma.
COVID-19 implications for addictions and mental health.
Strategies for prevention of mental health problems and suicide among people with addictions.
Addiction and neurodiversity.
Sessions
Wednesday, 23 November
10:50
Substance use, mental health and mental well-being: observations, interventions and recovery promotion
10:50
to
12:20
Networking zone 3 (N3)
Short communication session
Substance-induced psychosis: register-linkage research in Nordic countries
10:50
to
12:20
Knowledge market 2 (K2)
Structured session
15:00
Substance use and mental health disorders in Europe: prevalence, models of care, and implementation in a challenging COVID-19 context
15:00
to
16:30
Knowledge market 2 (K2)
Structured session
Understanding relationships between substance use, mental health and mental illness: Session 1
15:00
to
16:30
Networking zone 2 (N2)
e-poster guided tour
16:50
Addiction and comorbidity over the lifespan: mechanisms and interventions
16:50
to
18:20
Central square 2 (C2)
Structured session
Impact and lessons learned in implementing and sustaining Needs-Based Planning models for substance use and mental health services and systems
16:50
to
18:20
Knowledge market 2 (K2)
Structured session
Thursday, 24 November
10:50
Substance use and trauma
10:50
to
12:20
Knowledge market 2 (K2)
Oral presentation session
13:20
Childhood risk factors in substance use and mental health
13:20
to
14:50
Knowledge market 2 (K2)
Oral presentation session
15:00
Substance use and mental health during COVID-19
15:00
to
16:30
Knowledge market 2 (K2)
Oral presentation session
Understanding relationships between substance use, mental health and mental illness: Session 2
15:00
to
16:30
Networking zone 2 (N2)
e-poster guided tour
16:50
Substance use, suicide and self-harm: epidemiology and prevention
16:50
to
18:20
Main stage
Structured session
Friday, 25 November
10:50
Associations of alcohol and substance use with mental health
10:50
to
12:20
Knowledge market 2 (K2)
Structured session
13:20
Stress and Addiction: Updates on the Chicken or Egg question
13:20
to
14:50
Central square 4 (C4)
Structured session
Substance use, mental health risk and suicide
13:20
to
14:50
Knowledge market 2 (K2)
Oral presentation session
Presentations
Wednesday, 23 November
10:50
Short communication
The temporal association between frequency of methamphetamine use, depression, and anxiety in a community-recruited cohort of methamphetamine smokers
10:50
to
12:20
Networking zone 3 (N3)
Zoe Duncan
Short communication
Effectiveness of mental health warnings on tobacco packaging in people with and without common mental health conditions: an online randomised experiment
10:50
to
12:20
Networking zone 3 (N3)
Katherine Sawyer
Short communication
A realist evaluation of greenspace programmes for improving mental health and supporting people with problem substance use
10:50
to
12:20
Networking zone 3 (N3)
Wendy Masterton
Oral presentation
1. Annual incidence of substance-induced psychoses in Scandinavia from 2000 to 2016
10:50
to
12:20
Knowledge market 2 (K2)
Eline Borger Rognli
Short communication
Association between cannabis use and mental health disorders in adolescents in Catalonia: results of a cohort study
10:50
to
12:20
Networking zone 3 (N3)
Regina Muñoz-Galán
Oral presentation
2. Characteristics of incident substance-induced psychosis compared to incident first episode psychosis. A nationwide register-linkage study
10:50
to
12:20
Knowledge market 2 (K2)
Pihla Sassi
Short communication
Physical activity during treatment for substance use disorder: What a systematic review tells us
10:50
to
12:20
Networking zone 3 (N3)
Florence Piché
Oral presentation
3. Relapse rate of substance-induced psychosis and associated risk factors. A nationwide registerlinkage study
10:50
to
12:20
Knowledge market 2 (K2)
Heidi Taipale
Short communication
Drug use, anxiety and depression among people living in prison in Belgium
10:50
to
12:20
Networking zone 3 (N3)
Kim Fernandez
Oral presentation
4. Substance-induced psychosis and later schizophrenia or bipolar disorder: transition rates and the role of infections
10:50
to
12:20
Knowledge market 2 (K2)
Jørgen G. Bramness
Oral presentation
5. Antipsychotic use and associating factors among persons with substance-induced psychosis and first-episode psychosis. A nationwide register-linkage study
10:50
to
12:20
Knowledge market 2 (K2)
Jeyaniroshan Jeyapalan
Short communication
Mental Health and Addiction Prevention for former refugees: We do it together
10:50
to
12:20
Networking zone 3 (N3)
Jannet De Jonge
15:00
e-poster
A systematic review and meta-analyses of longitudinal studies on mood and anxiety symptoms following prescription opioid use.
15:00
to
16:30
Networking zone 2 (N2)
Janni Leung
e-poster
Vicarious trauma among nurses working in addiction services and the role of leadership: a European mixed methods study
15:00
to
16:30
Networking zone 2 (N2)
K. Nicki Annunziata
e-poster
Cognitive screening for long term substance use outcome in a cohort of patients with polysubstance use disorder
15:00
to
16:30
Networking zone 2 (N2)
Jens Hetland
e-poster
Anhedonia during recovery of polysubstance use
15:00
to
16:30
Networking zone 2 (N2)
Aleksander Erga
e-poster
COVID-19 pandemic induces severe impact on substances administration and on aspects of psychosocial life of patients under methadone and buprenorphine maintenance treatment
15:00
to
16:30
Networking zone 2 (N2)
Vasilios Stavropoulos
Oral presentation
1. What do we mean by psychiatric comorbidity or dual disorders?
15:00
to
16:30
Knowledge market 2 (K2)
Marta Torrens
e-poster
Bridging the Gap in Violence Prevention and Mental Health Support through Culturally Relevant Community-Led Initiatives.
15:00
to
16:30
Networking zone 2 (N2)
Rita Gatonye
Oral presentation
2. Impact of Covid19 on mental health and drug use: main findings from the EMCDDA trendspotter study
15:00
to
16:30
Knowledge market 2 (K2)
Franca Beccaria
Oral presentation
3. Psychiatric comorbidity in the European countries: prevalence and models of care
15:00
to
16:30
Knowledge market 2 (K2)
Francina Fonseca
Oral presentation
4. The dual diagnosis inpatient and outpatient treatment program in Ljubljana: practical implementatio
15:00
to
16:30
Knowledge market 2 (K2)
Nusa Segrec,
Andrej Kastelic
Discussion
Discussion: Substance use and mental health disorders in Europe
15:00
to
16:30
Knowledge market 2 (K2)
Gabriele Fischer
16:50
Oral presentation
1. Implementation of a substance use NBP model in a Northern Region of Ontario- results and lessons learned
16:50
to
18:20
Knowledge market 2 (K2)
Stephanie Paquette
Oral presentation
1. First findings of an RCT on treatment of PTSD in addiction: simultaneous or sequential treatment with EMDR, Prolonged Exposure, Imaginary Rescripting
16:50
to
18:20
Central square 2 (C2)
Nathalie Faber
Oral presentation
3. Development and pilot testing an integrated mental health and substance use Needs-based Planning model: Lessons learned for local planning and model refinements
16:50
to
18:20
Knowledge market 2 (K2)
Brian Rush
Oral presentation
2. Older adults and alcohol use: negative affect, resilience, and alcohol use as interacting factors
16:50
to
18:20
Central square 2 (C2)
Yannick van Gils
Oral presentation
5. Focus on implementation processes, impacts to date and pros and cons of the sustainability of the Australian Mental Health model
16:50
to
18:20
Knowledge market 2 (K2)
Sandra Diminic
Oral presentation
3. Effectiveness of a digital alcohol moderation intervention as an add-on to depression treatment for young adults: findings of a pragmatic randomized controlled trial
16:50
to
18:20
Central square 2 (C2)
Maria J.E. Schouten
Oral presentation
4. Illegal substance use during pregnancy: what do we know about risks and detoxification?
16:50
to
18:20
Central square 2 (C2)
Cleo L. Crunelle
Oral presentation
2. Impact and lessons learned in the implementation of a NBP model across the province of Quebec, Canada
16:50
to
18:20
Knowledge market 2 (K2)
Joël Tremblay
Discussion
Strategic approach to service prioritization and resource allocation
16:50
to
18:20
Knowledge market 2 (K2)
Daniel Vigo
Thursday, 24 November
10:50
Oral presentation
The association between moral injury and cannabis use disorder among Israeli combat veterans: current state of knowledge and future directions
10:50
to
12:20
Knowledge market 2 (K2)
Daniel Feingold
Oral presentation
Alcohol and drug use among trauma patients with injuries of violence– results from the IDART study
10:50
to
12:20
Knowledge market 2 (K2)
Benedicte Jørgenrud
Oral presentation
addictive disorders and post-traumatic stress disorders
10:50
to
12:20
Knowledge market 2 (K2)
Léa Montagnier
Oral presentation
A novel trauma-focused psychological therapy for co-occurring substance use and PTSD among adolescents
10:50
to
12:20
Knowledge market 2 (K2)
Emma Barrett
13:20
Oral presentation
Longitudinal patterns of problematic cannabis use in adolescence and their association with childhood psychological risk factors
13:20
to
14:50
Knowledge market 2 (K2)
Rachel Lees
Oral presentation
Childhood maltreatment and alcohol problems in young adulthood: coping style as a mediator and potential intervention target.
13:20
to
14:50
Knowledge market 2 (K2)
Lucinda Grummitt
Oral presentation
Exploring the link between childhood maltreatment and substance use disorder using a prospective, genetically informative and experimental approach
13:20
to
14:50
Knowledge market 2 (K2)
Andrea Johansson Capusan
Oral presentation
The Role of Adverse Childhood Experiences (ACEs) on People in Opiate Agonist Treatment: The importance of feeling unloved
13:20
to
14:50
Knowledge market 2 (K2)
David McDonagh
15:00
Oral presentation
The role of place-making dynamics in recovery from co-occurring disorders: An in-depth ethnographic study
15:00
to
16:30
Knowledge market 2 (K2)
Clara De Ruysscher
e-poster
Program 'Eu e os Outros': Adaptation to the university context
15:00
to
16:30
Networking zone 2 (N2)
Mariana Montalvão
e-poster
Khat and neurobehavioral functions: a systematic review
15:00
to
16:30
Networking zone 2 (N2)
Manuel Jesús Ruiz Muñoz
e-poster
Group Intervention for Parents of People With Psychotic and Substance Use Disorders: A Qualitative Evaluation of appropriateness
15:00
to
16:30
Networking zone 2 (N2)
Karine Gaudreault
e-poster
How Attention Deficit Hyperactivity Disorder and Substance Use Disorder influence each other: A non-systematic literature review
15:00
to
16:30
Networking zone 2 (N2)
Catarina Oliveira
e-poster
Smoking-related health inequalities, tobacco smoking and substance use disorder.
15:00
to
16:30
Networking zone 2 (N2)
Mireia Graell Gabriel
e-poster
Substance-Related Problems in Adolescents with ADHD-Diagnoses: The Importance of Self-Reported Conduct Problems
15:00
to
16:30
Networking zone 2 (N2)
Ove Heradstveit
Oral presentation
Changes in mental health among drug users during Covid-19. Evidence from a repeated cross-sectional survey in Belgium
15:00
to
16:30
Knowledge market 2 (K2)
Elena Damian
Oral presentation
Online peer support for concurring mental health and addiction problems during the Covid19 pandemic: feeling of group inclusion and perceived effectiveness.
15:00
to
16:30
Knowledge market 2 (K2)
Raffaella Milani
e-poster
The Clinical Course of Comorbid Substance Use Disorder and Attention Deficit/Hyperactivity Disorder: Protocol and Clinical Characteristics of the INCAS Study
15:00
to
16:30
Networking zone 2 (N2)
Johan Franck
16:50
Oral presentation
Suicide and self-harm during COVID-19 and beyond.
16:50
to
18:20
Main stage
Navneet Kapur
Oral presentation
Adolescent substance use, self-harm and suicide: Findings from the Northern Finland Birth Cohort 1986.
16:50
to
18:20
Main stage
Solja Niemelä
Oral presentation
Restricting access to means: Public health approaches to reduce drug- and alcohol-related self-harm.
16:50
to
18:20
Main stage
Eve Griffin
Friday, 25 November
10:50
Oral presentation
1. Socioeconomic status, alcohol use and the mediating role of social support and neighbourhood disadvantage among individuals meeting criteria for a mental health problem: a cross-sectional study
10:50
to
12:20
Knowledge market 2 (K2)
Jo-Anne Puddephatt
Oral presentation
2. The association between mental health and alcohol use in racial and ethnic groups: A secondary data analysis across studies
10:50
to
12:20
Knowledge market 2 (K2)
Laura Goodwin
Oral presentation
3. Association of psychological distress with smoking cessation, duration of smoking abstinence and use of other nicotine-containing products: A cross-sectional population survey in Great Britain
10:50
to
12:20
Knowledge market 2 (K2)
Leonie Brose
Oral presentation
4. Can we make cannabis safer? An experimental study of four CBD: THC rations in healthy volunteers
10:50
to
12:20
Knowledge market 2 (K2)
Amir Englund
Discussion
Commonalities across the research on different substances
10:50
to
12:20
Knowledge market 2 (K2)
Abi Rose
13:20
Oral presentation
Hazardous, harmful and dependent alcohol use in Crisis Resolution Team patients: relationship with death or service recontact after a suicidal crisis.
13:20
to
14:50
Knowledge market 2 (K2)
John Robins
Oral presentation
Comparing characteristics of suicide to non-suicide drug poisoning, by sex, in Ireland.
13:20
to
14:50
Knowledge market 2 (K2)
Ena Lynn
Oral presentation
Characteristics associated with suicide among people who use drugs in Ireland 2015 to 2017: a repeated cross-sectional study
13:20
to
14:50
Knowledge market 2 (K2)
Suzi Lyons
Oral presentation
Implementation of a community-based psychiatric intervention among people who inject drugs in the City of Haiphong, Vietnam: the DRIVE-Mind project
13:20
to
14:50
Knowledge market 2 (K2)
Laurent Michel
Oral presentation
The impact of detoxification on suicidal behaviour among heroin users: longitudinal data from South Africa
13:20
to
14:50
Knowledge market 2 (K2)
Nirvana Morgan
Oral presentation
1. Cue-induced cocaine craving enhances psychosocial stress and vice versa in chronic cocaine users
13:20
to
14:50
Central square 4 (C4)
Boris Quednow
Oral presentation
2. The endocannabinoid system and drug addiction: basal and stress-related endocannabinoid plasma levels in chronic cocaine users and prescription opioid users
13:20
to
14:50
Central square 4 (C4)
Sara Kroll
Oral presentation
3. The endocannabinoid system as a potential buffer against the development of a substance use disorder following childhood trauma exposure
13:20
to
14:50
Central square 4 (C4)
Leah M. Mayo
Oral presentation
4. Understanding the mechanisms that link childhood stress with risk of addiction
13:20
to
14:50
Central square 4 (C4)
Molly Carlyle
Oral presentation
5. Is opioid liking driven by relief or reward? Evidence from clinical and experimental studies of acute stress
13:20
to
14:50
Central square 4 (C4)
Isabell M. Meier
View all tracks
Next track